Wall Street brokerages forecast that Innospec Inc. (NASDAQ:IOSP) will announce earnings per share (EPS) of $1.35 for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Innospec’s earnings. Innospec posted earnings of $1.47 per share during the same quarter last year, which would indicate a negative year over year growth rate of 8.2%. The business is expected to report its next earnings results on Tuesday, February 12th.
According to Zacks, analysts expect that Innospec will report full-year earnings of $4.55 per share for the current financial year. For the next financial year, analysts anticipate that the firm will report earnings of $4.75 per share. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that follow Innospec.
Innospec (NASDAQ:IOSP) last released its quarterly earnings data on Tuesday, November 6th. The specialty chemicals company reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.06 by $0.14. The business had revenue of $363.10 million during the quarter, compared to the consensus estimate of $362.50 million. Innospec had a return on equity of 14.02% and a net margin of 4.17%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $1.00 EPS.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Innospec by 12.9% in the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,829 shares of the specialty chemicals company’s stock valued at $447,000 after purchasing an additional 667 shares in the last quarter. Strs Ohio increased its holdings in Innospec by 10.0% in the 2nd quarter. Strs Ohio now owns 8,800 shares of the specialty chemicals company’s stock valued at $673,000 after purchasing an additional 800 shares in the last quarter. United Services Automobile Association increased its holdings in Innospec by 4.2% in the 3rd quarter. United Services Automobile Association now owns 21,311 shares of the specialty chemicals company’s stock valued at $1,636,000 after purchasing an additional 856 shares in the last quarter. Rhumbline Advisers increased its holdings in Innospec by 1.6% in the 2nd quarter. Rhumbline Advisers now owns 60,522 shares of the specialty chemicals company’s stock valued at $4,633,000 after purchasing an additional 975 shares in the last quarter. Finally, BlueMountain Capital Management LLC increased its holdings in Innospec by 30.5% in the 2nd quarter. BlueMountain Capital Management LLC now owns 4,594 shares of the specialty chemicals company’s stock valued at $352,000 after purchasing an additional 1,073 shares in the last quarter. Hedge funds and other institutional investors own 94.21% of the company’s stock.
Shares of IOSP stock traded up $0.72 on Friday, reaching $73.74. 102,126 shares of the stock were exchanged, compared to its average volume of 82,786. The company has a market cap of $1.78 billion, a price-to-earnings ratio of 15.82 and a beta of 1.10. The company has a quick ratio of 1.37, a current ratio of 2.27 and a debt-to-equity ratio of 0.25. Innospec has a 1-year low of $62.13 and a 1-year high of $83.20.
The company also recently disclosed a semiannual dividend, which was paid on Thursday, November 29th. Stockholders of record on Monday, November 19th were issued a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, November 16th. This represents a dividend yield of 1.18%. Innospec’s payout ratio is 19.31%.
Innospec Company Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.
Read More: How to Invest in Marijuana Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.